Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Single-Payer Healthcare
  • Federal Workers’ Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

WHAT'S NEW

  • Single-Payer Healthcare
  • Federal Workers' Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Sep 25 2018

Full Issue

Money Managers Betting On Stability, Success Of Health Care Stocks

Rising interest in health care stocks coincides with surging profits across the industry. Plus, the needs of an aging population are expected to insulate companies from a downturn.

The Wall Street Journal: Health-Care Stocks Lead This Leg Of Rally, After Tech Giants’ Stumbles

Health-care stocks have emerged as market leaders in the third quarter, helping push major U.S. indexes to new highs. One reason: money managers are embracing the sector as a safety play, particularly after big technology stocks stumbled in September. (Wursthorn, 9/25)

In other news from the industry —

The Wall Street Journal: TPG In Exclusive Talks To Take Over Abraaj’s $1 Billion Health-Care Fund

U.S. private-equity firm TPG is in exclusive talks to take over Abraaj Group’s $1 billion health-care fund, according to a letter to employees of the fund. Abraaj was the largest private-equity firm in the Middle East with almost $14 billion of assets until it filed for provisional liquidation in June. The Dubai-based firm is selling assets and winding down operations. It got into difficulty in 2017 after investors in its health-care fund, including the Bill & Melinda Gates Foundation and the World Bank, started investigating whether their money was being mismanaged. (Clark and Louch, 9/24)

Bloomberg: J&J Talc Cancer Case Ends In Mistrial With Divided Jury 

Johnson & Johnson’s latest trial over claims that its baby powder causes cancer ended in a stalemate when jurors couldn’t agree on a verdict. A state judge in Pasadena, California, declared a mistrial Monday after jurors deadlocked on Carolyn Weirick’s request for at least $25 million in damages over her mesothelioma, a cancer linked to asbestos exposure. Weirick said she developed the disease from asbestos-laced baby powder. (Feeley, Fisk and Favot, 9/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF